QUADRANGLE GP INVESTORS LLC
Follow13F filer, CIK 1281082, New York, NY
QUADRANGLE GP INVESTORS LLC reported $144,810,000 across 3 holdings for the quarter ended 2016-03-31, in a 13F-HR filed 2016-05-02.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-16-003616
Changes against Q4 2015 are not shown: its report omitted holdings under a confidential treatment request (3 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2016-03-31
- Reported value
- $145M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q1 2016
Share positions as resolved from 13F-HR 0000950142-16-003616, largest first. % of portfolio is the value over $144,810,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| WEST CORPWEST CORP | 3,781,961 | $86.3M | 59.6% | The filing omitted confidential holdings, a later amendment may add them. | |||
| NTELOS HLDGS CORPNTELOS HLDGS CORP | 4,180,837 | $38.5M | 26.56% | The filing omitted confidential holdings, a later amendment may add them. | |||
| DHXDHI GROUP INC | 2,483,661 | $20M | 13.84% | The filing omitted confidential holdings, a later amendment may add them. | Timeline |
How Q1 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950142-16-003616 | base | 2016-05-02 | acceptance time not in the bulk data set |